HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Tateda Selected Research

Cytokines

5/2019Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases.
1/2019Role of interleukin-17 in a murine community-associated methicillin-resistant Staphylococcus aureus pneumonia model.
1/2019Overlapping Roles for Interleukin-36 Cytokines in Protective Host Defense against Murine Legionella pneumophila Pneumonia.
8/2016Endogenous IL-17 as a factor determining the severity of Clostridium difficile infection in mice.
8/2013Effects of slow-releasing colistin microspheres on endotoxin-induced sepsis.
3/2012Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model.
12/2004Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection.
11/2001Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines.
5/2001Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection.
11/2000Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Tateda Research Topics

Disease

50Infections
12/2022 - 10/2000
36Pneumonia (Pneumonitis)
07/2021 - 11/2000
18Communicable Diseases (Infectious Diseases)
08/2023 - 06/2005
11COVID-19
06/2023 - 12/2020
8Necrosis
04/2021 - 10/2000
7Sepsis (Septicemia)
01/2020 - 06/2005
5Clostridium Infections
03/2024 - 08/2016
4Pneumococcal Pneumonia
10/2016 - 08/2003
4Hyperoxia
10/2013 - 04/2003
3Septic Shock (Toxic Shock Syndrome)
02/2024 - 05/2019
3Surgical Wound Infection
11/2023 - 01/2020
3Respiratory Tract Infections (Respiratory Tract Infection)
08/2023 - 01/2008
3Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
04/2021 - 02/2010
3Acute Lung Injury
11/2010 - 04/2003
2Bacteremia
12/2023 - 09/2009
2Mycoses (Diseases, Fungus)
02/2023 - 08/2018
2Pulmonary Aspergillosis
02/2023 - 01/2017
2Legionellosis
02/2022 - 02/2010
2Colitis
01/2020 - 01/2019
2Cough
06/2019 - 11/2017
2Inflammation (Inflammations)
01/2019 - 12/2004
2Shock
12/2017 - 08/2013
2Fever (Fevers)
11/2017 - 10/2002
2Cross Infection (Nosocomial Infection)
11/2017 - 08/2017
2Pneumococcal Infections
01/2013 - 01/2008
2Legionnaires' Disease (Legionnaire's Disease)
04/2006 - 06/2002
1Chromosome Inversion (Chromosomal Inversion)
02/2024
1Cellulitis
12/2023
1Multiple Myeloma
12/2023
1Aspergillosis
02/2023
1Mucormycosis
02/2023
1Drug-Related Side Effects and Adverse Reactions
02/2023
1Cryptococcosis
02/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023

Drug/Important Bio-Agent (IBA)

14Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 12/2007
14AntigensIBA
02/2021 - 06/2002
11CytokinesIBA
05/2019 - 10/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009 - 10/2000
6VancomycinFDA LinkGeneric
03/2024 - 01/2019
6Anti-Infective Agents (Microbicides)IBA
08/2023 - 07/2011
5Interleukin-6 (Interleukin 6)IBA
12/2017 - 10/2000
5MacrolidesIBA
10/2016 - 12/2007
5Azithromycin (Zithromax)FDA LinkGeneric
10/2016 - 12/2004
4Carbapenems (Carbapenem Antibiotics)IBA
10/2021 - 04/2014
4FidaxomicinIBA
07/2020 - 09/2018
4Interleukin-17 (Interleukin 17)IBA
01/2020 - 03/2012
4FluoroquinolonesIBA
01/2020 - 12/2004
4C-Reactive ProteinIBA
06/2019 - 01/2008
4InterleukinsIBA
01/2019 - 11/2001
3Immunoglobulin G (IgG)IBA
11/2021 - 09/2021
3Indicators and Reagents (Reagents)IBA
02/2021 - 01/2005
3Colistin (Coly-Mycin)FDA Link
12/2017 - 03/2009
3ImipenemFDA Link
09/2017 - 01/2013
3Virulence Factors (Pathogenicity Factors)IBA
08/2017 - 10/2003
3LipopolysaccharidesIBA
08/2013 - 10/2000
3Capsules (Microcapsules)IBA
06/2011 - 11/2000
3Interleukin-1 (Interleukin 1)IBA
09/2009 - 01/2005
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2009 - 08/2001
2PowdersIBA
11/2023 - 01/2020
2EnzymesIBA
06/2021 - 01/2013
2Linezolid (Zyvox)FDA Link
02/2020 - 04/2012
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2019 - 11/2017
2Panton-Valentine leukocidinIBA
01/2018 - 07/2015
2InterferonsIBA
01/2018 - 11/2001
2Clarithromycin (Biaxin)FDA LinkGeneric
11/2017 - 02/2010
2Interleukin-10 (Interleukin 10)IBA
02/2017 - 05/2001
2polyglucosanIBA
01/2017 - 01/2008
2SteroidsIBA
07/2015 - 01/2015
2CalciumIBA
10/2013 - 11/2010
2AntioxidantsIBA
10/2013 - 08/2004
2Edetic Acid (EDTA)FDA Link
10/2013 - 11/2010
2AcidsIBA
10/2013 - 02/2010
2EndotoxinsIBA
08/2013 - 06/2010
2EDP 420IBA
07/2011 - 04/2011
2Methotrexate (Mexate)FDA LinkGeneric
01/2011 - 01/2008
2DNA (Deoxyribonucleic Acid)IBA
03/2010 - 04/2003
2Ciprofloxacin (Cipro)FDA LinkGeneric
02/2010 - 12/2004
2Erythromycin (Erycette)FDA LinkGeneric
12/2007 - 01/2004
2Oxygen (Dioxygen)IBA
08/2004 - 04/2003
2Interferon-gamma (Interferon, gamma)IBA
11/2001 - 05/2001
2factor AIBA
05/2001 - 11/2000
1Metronidazole (Metric)FDA LinkGeneric
03/2024
1Leukocidins (Leukocidin)IBA
02/2024
1Staphylococcal enterotoxin FIBA
02/2024
1immunoglobulin BIBA
06/2023
1isavuconazoleIBA
02/2023
1Voriconazole (Vfend)FDA LinkGeneric
02/2023
1Meropenem (Merrem)FDA LinkGeneric
12/2022
1VaccinesIBA
12/2022
1Antiviral Agents (Antivirals)IBA
12/2022
1Viral RNAIBA
09/2022
1Uric Acid (Urate)IBA
04/2022
1favipiravirIBA
04/2022
1Nucleic AcidsIBA
02/2022
1homocysteine-thiolactone-nicotinamide (ST 22)IBA
01/2022
1AntibodiesIBA
09/2021

Therapy/Procedure

15Therapeutics
01/2023 - 08/2004
11Drug Therapy (Chemotherapy)
12/2023 - 12/2007
2Aftercare (After-Treatment)
07/2021 - 01/2004
2Oral Administration
03/2014 - 02/2007